Looby, Sara E.; Kantor, Amy; Burdo, Tricia H.; Currier, Judith S.; Fichtenbaum, Carl J.; Overton, Edgar T.; Aberg, Judith A.; Malvestutto, Carlos D.; Bloomfield, Gerald S.; Erlandson, Kristine M.; Kallas, Esper Georges 
Source: Clinical infectious diseases. Unidade: FM
Subjects: TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE, HIV, MORTALIDADE, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOOBY, Sara E. et al. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clinical infectious diseases, v. 75, n. 8, p. 1324-1333, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50552. Acesso em: 09 nov. 2024.APA
Looby, S. E., Kantor, A., Burdo, T. H., Currier, J. S., Fichtenbaum, C. J., Overton, E. T., et al. (2022). Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clinical infectious diseases, 75( 8), 1324-1333. doi:10.1093/cid/ciac166NLM
Looby SE, Kantor A, Burdo TH, Currier JS, Fichtenbaum CJ, Overton ET, Aberg JA, Malvestutto CD, Bloomfield GS, Erlandson KM, Kallas EG. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy [Internet]. Clinical infectious diseases. 2022 ; 75( 8): 1324-1333.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50552Vancouver
Looby SE, Kantor A, Burdo TH, Currier JS, Fichtenbaum CJ, Overton ET, Aberg JA, Malvestutto CD, Bloomfield GS, Erlandson KM, Kallas EG. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy [Internet]. Clinical infectious diseases. 2022 ; 75( 8): 1324-1333.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50552
